Copy Number Variation in Tumor Cells and Extracellular DNA in Patients with Lung Adenocarcinoma
- 作者: Kutilin D.S.1, Airapetova T.G.1, Anistratov P.A.1, Pyltsin S.P.1, Leiman I.A.1, Karnaukhov N.S.1, Kit O.I.1
-
隶属关系:
- Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
- 期: 卷 167, 编号 6 (2019)
- 页面: 771-778
- 栏目: Oncology
- URL: https://journal-vniispk.ru/0007-4888/article/view/242108
- DOI: https://doi.org/10.1007/s10517-019-04620-y
- ID: 242108
如何引用文章
详细
Copy number variation of some gene loci in lung tumor cells extracted by laser capture microdissection and in cell-free DNA in the plasma of patients with lung cancer was analyzed for identification of potential molecular markers. Tissue specimens fixed in formalin and embedded in paraffin blocks (FFPE-blocks) from 90 patients and extracellular DNA from plasma samples of 70 patients and 30 donors were used. Copy number variation was assayed for 30 genes (BAX, BCL2, C-FLAR, P53, MDM2, CASP9, CASP3, CASP8, SOX2, OCT4, PIK3, MKI67, HV2, HIF1A1, XRCC1, MMP1, TERT, CTNNB1, KRAS, EGFR, GRB2, SOS1, MAPK1, STAT1, BRAF, FTO, and mir3678) and reference loci (ACTB, B2M, and GAPDH) by the real-time quantitative PCR. Changed copy numbers were detected for genes responsible for apoptosis regulation (BAX, P53, and CASP3), proliferation (SOX2), DNA reparation (XRCC1), oxidative phosphorylation (HV2), EGFR signaling pathway (GRB2, SOS1, MAPK1, STAT1, and BRAF), and for mir3678 gene in lung tumor cells and extracellular DNA.
作者简介
D. Kutilin
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
编辑信件的主要联系方式.
Email: k.denees@yandex.ru
俄罗斯联邦, Rostov-on-Don
T. Airapetova
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: k.denees@yandex.ru
俄罗斯联邦, Rostov-on-Don
P. Anistratov
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: k.denees@yandex.ru
俄罗斯联邦, Rostov-on-Don
S. Pyltsin
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: k.denees@yandex.ru
俄罗斯联邦, Rostov-on-Don
I. Leiman
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: k.denees@yandex.ru
俄罗斯联邦, Rostov-on-Don
N. Karnaukhov
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: k.denees@yandex.ru
俄罗斯联邦, Rostov-on-Don
O. Kit
Rostov Research Institute of Oncology, Ministry of Health of the Russian Federation
Email: k.denees@yandex.ru
俄罗斯联邦, Rostov-on-Don
补充文件
